Leidos Holdings, Inc. (LDOS.MX)
| Previous close | 2,758.53 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 2,758.53 - 2,758.53 |
| 52-week range | 1,613.00 - 2,758.53 |
| Volume | |
| Avg. volume | 2 |
| Market cap | 411.548B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | 43.67 |
| EPS (TTM) | 63.17 |
| Earnings date | 29 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | 28.05 (1.02%) |
| Ex-dividend date | 13 Sept 2024 |
| 1y target est | N/A |
Simply Wall St.Is Leidos Holdings, Inc. (NYSE:LDOS) Trading At A 30% Discount?
Key Insights The projected fair value for Leidos Holdings is US$221 based on 2 Stage Free Cash Flow to Equity Leidos...
PR NewswireLeidos awarded CDC's National Health Safety Network modernization contract
Leidos (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN) Development, Maintenance, Support, and Modernization contract by the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases. Leidos will leverage its data management and mission software expertise to continue delivering a secure NHSN platform, including the necessary support applications and inputs from partnering feder
- PR Newswire
Leidos awarded $51 million contract to enhance missile warning capabilities
Leidos (NYSE:LDOS), a Fortune 500® innovation leader, was recently awarded a Missile Warning/Missile Track Enhancement (MW/MT) contract by the Space Systems Command, Strategic Warning and Surveillance Systems Acquisition Delta. Leidos will provide mission software and technology-enabled services to enhance missile warning capabilities for the Combatant Commanders Integrated Command and Control Systems (CCIC2S). The award has a base period of performance of 54 months.
